Related Experiment Video
Updated: Aug 20, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
Reovirus oncolysis in human head and neck squamous carcinoma cells
Yoichi Ikeda1, Goshi Nishimura, Shunsuke Yanoma
1Department of Head and Neck Surgery, Kanagawa Cancer Center, Asahi-ku, Yokohama 241-0815, Japan. ikeda.y@jcom.home.ne.jp
Objective:
To determine whether reovirus, a double-standed RNA virus is effective on the growth of a human head and neck squamous cell carcinoma cell line.
Designs:
In vitro cell proliferation assay, KB cells, a human oral floor squamous cell carcinoma cell line, were treated with reovirus and the number of cells was quantitated by an assay, using trypan blue staining. In vivo tumor growth assay, KB cells were injected subcutaneously into athymic nude mice, which were given an intratumoral injection of reovirus to a maximum four times in every week. The tumor size was measured once a week. Simultaneously, apoptosis and necrosis of KB cells were investigated, using technique of immunohistochemistry.
Results:
In vitro, the multiplication of the KB cell was inhibited depending on the concentration of reovirus. In vivo, athymic nude mice bearing KB tumors were injected with the virus intratumorally, and the tumor growth was suppressed proportionally depending on the injection time of reovirus. Necrosis was recognized extensively in the pathological specimen. On the other hand, apoptosis-inducing effect was not obvious in these specimen.
Conclusions:
Reovirus suppressed tumor growth of KB cells in vivo as well as in vitro. The possibility that reovirus could become the means of treatment for head and neck carcinoma, was suggested with further work.
Insights
Reovirus effectively inhibited the growth of human head and neck squamous cell carcinoma (HNSCC) cells in laboratory and animal studies. This suggests reovirus as a potential therapeutic agent for HNSCC.
Area of Science:
- Oncolytic virotherapy
- Cancer research
- Head and neck squamous cell carcinoma (HNSCC)
Background:
- Head and neck squamous cell carcinoma (HNSCC) remains a significant health challenge.
- Novel therapeutic strategies are needed to improve HNSCC treatment outcomes.
Purpose of the Study:
- To evaluate the efficacy of reovirus, a double-stranded RNA virus, against human HNSCC cell lines.
- To investigate the anti-tumor effects of reovirus in both in vitro and in vivo models of HNSCC.
Main Methods:
- In vitro proliferation assays using KB cells (HNSCC cell line) treated with reovirus.
- In vivo tumor growth assays in athymic nude mice xenograft models with intratumoral reovirus injections.
- Immunohistochemical analysis to assess apoptosis and necrosis in tumor tissues.
Main Results:
- Reovirus demonstrated dose-dependent inhibition of KB cell proliferation in vitro.
- Intratumoral reovirus administration suppressed tumor growth in vivo proportionally to treatment frequency.
- Extensive tumor necrosis was observed, while apoptosis induction was not prominent.
Conclusions:
- Reovirus exhibits significant anti-tumor activity against HNSCC cells in vitro and in vivo.
- Reovirus holds promise as a potential therapeutic agent for head and neck cancer, warranting further investigation.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

